Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2025-12-25 @ 8:05 PM
Study NCT ID:
NCT04851535
Status:
COMPLETED
Last Update Posted:
2023-11-03
First Post:
2021-04-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Jaktinib In Patients With Myelofibrosis Who Were Relapsed or Refractory of Ruxolitinib Treatment.
Sponsor:
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-08
First Submit QC Date:
None
Study First Post Date:
2021-04-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-01
Last Update Post Date:
2023-11-03
Last Update Post Date Type:
ACTUAL